Lung Biopsy Systems Market - Top Companies and Manufacturers

In the year 2024, the industry size of lung biopsy systems is assessed at USD 3.94 Billion.

The lung biopsy systems market size was valued at USD 3.46 Billion in 2023 and is set to reach USD 22.28 Billion by the end of 2036, expanding at around 15.4% CAGR during the forecast period i.e., between 2024-2036. Higher prevalence of lung cancer across the globe and the growing inclination toward minimally invasive surgeries are the major factors driving the growth of the market.

North America industry is predicted to account for the largest share of 42% by 2036, impelled by growing research and clinical trials to test a new approach to treatment for lung cancer in the region.

Argon Medical Devices, Inc., Fujifilm Corporation, Cardinal Health, Inc., DTR Medical Ltd, B. Braun Melsungen AG, Becton, Dickinson and Company, Olympus Corporation, Hologic Inc., Medtronic Limited, Zimmer Biomet Holdings, Inc